SBI Securities’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
SBCM
SBI Securities's SOPH Position: Q3 2026 in Review
SBI Securities reduced its SOPHiA GENETICS (SOPH) stake by 82% in Q3 2026, selling an estimated $194 and leaving 6 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #3732.
SBI Securities first reported a position in SOPH in Q3 2025 and has held it in 5 quarters since. The position peaked at $223 in Q1 2026. 10 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.
- SBI Securities held 6 shares of SOPHiA GENETICS worth $50 as of Q3 2026.
- SBI Securities sold 27 SOPHiA GENETICS shares in Q3 2026, an estimated $194.
- SOPHiA GENETICS made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3732 holding.
- SBI Securities first reported a position in SOPHiA GENETICS in Q3 2025 and has held it in 5 quarters since.
- SBI Securities's SOPHiA GENETICS position peaked at $223 in Q1 2026.
- 10 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.